Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding

Journal of Virology

Volumn 80, Issue 24, 2006, Pages 12131-12140

  McLinden, James H ^a   Kaufman, Thomas M ^a   Xiang, Jinhua ^a   Chang, Qing ^a   Klinzman, Donna ^a   Engel, Alfred M ^b   Hess, Georg ^b   Schmidt, Urban ^b   Houghton, Michael ^c   Stapleton, Jack T ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2; HUMAN CONVALESCENT POLYCLONAL ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; EPITOPE MAPPING; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; CELL LINE; EPITOPE MAPPING; GB VIRUS C; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT;

FLAVIVIRUS; GB VIRUS C; MURINAE;

EID: 33845452807     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01206-06     Document Type: Article

References (43)

1. Alter, H. J. 1997. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 37:569-572.
2. Belyaev, A. S., S. Chong, A. Novikov, A. Kongpachith, F. R. Masiarz, M. Lim, and J. P. Kim. 1998. Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins. J. Virol. 72:868-872.
3. Feucht, H. H., B. Zollner, S. Polywka, B. Knodler, M. Schroter, H. Nolte, and R. Laufs. 1997. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 26:491-494.
4. Fogeda, M., S. Navas, J. Martin, M. Casqueiro, E. Rodriguez, C. Arocena, and V. Carreno. 1999. In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J. Virol. 73:4052-4061.
5. George, S. L., D. Varmaz, and J. T. Stapleton. 2006. GB virus C replicates in primary T and B lymphocytes. J. Infect. Dis. 193:451-454.
6. George, S. L., J. Xiang, and J. T. Stapleton. 2003. Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 316:191-201.
7. Habersetzer, F., A. Fournillier, J. Dubuisson, D. Rosa, S. Abrignani, C. Wychowski, I. Nakano, C. Trepo, C. Desgranges, and G. Inchauspe. 1998. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology 249:32-41.
8. Hadlock, K. G., R. E. Lanford, S. Perkins, J. Rowe, Q. Yang, S. Levy, P. Pileri, S. Abrignani, and S. K. H. Foung. 2000. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J. Virol. 74:10407-10416.
9. Hassoba, H. M., M. G. Pessoa, N. A. Terrault, N. J. Lewis, M. Hayden, J. C. Hunt, X. Qiu, S. C. Lou, and T. L. Wright. 1998. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model. J. Med. Virol. 56:253-258.
10. Jung, S., O. Knauer, N. Donhauser, M. Eichenmuller, M. Helm, B. Fleckenstein, and H. Reil. 2005. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 19:1267-1272.
11. Larios, C., J. Casas, M. A. Alsina, C. Mestres, M. J. Gomara, and I. Haro. 2005. Characterization of a putative fusogenic sequence in the E2 hepatitis G protein. Arch. Biochem. Biophys. 442:149-159.
12. Larios, C., B. Christiaens, M. J. Gomara, M. A. Alsina, and I. Hara. 2005. Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles. FEBS J. 272:2456-2466.
13. Laskus, T., M. Radkowski, L. F. Wang, H. Vargas, and J. Rakela. 1998. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J. Virol. 72:3072-3075.
14. Leary, T. P., A. S. Muerhoff, J. N. Simons, T. J. Pilot-Matias, J. C. Erker, M. L. Chalmers, G. G. Schlauder, G. J. Dawson, S. M. Desai, and I. K. Mushahwar. 1996. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J. Med. Virol. 48:60-67.
15. Linnen, J., J. Wages, Z.-Y. Zhang-Keck, K. E. Fry, K. Z. Krawczynski, H. Alter, E. Koonin, M. Gallagher, M. Alter, S. Hadziyannis, P. Karayiannis, K. Fung, Y. Nakatsuji, J. W. K. Shih, M. Piatak, C. Hoover, J. Fernandez, S. Chen, J.-C. Zou, T. Morris, K. C. Hyams, S. Ismay, J. D. Lifson, G. Hess, S. K. H. Foung, H. Thomas, D. Bradley, H. Margolis, and J. P. Kim. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion- transmissible agent. Science 271:505-508.
16. Nattermann, J., H. D. Nischalke, B. Kupfer, J. Rockstroh, L. Hess, T. Sauerbruch, and U. Spengler. 2003. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17:1457-1462.
17. Okamoto, H., H. Nakao, T. Inoue, M. Fukuda, J. Kishimoto, H. Iizuka, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1997. The entire nucleotide sequence of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J. Gen. Virol. 78:737-745.
18. Pessoa, M. G., N. A. Terrault, J. Detmer, J. Kolberg, M. Colllins, H. M. Hassoba, and T. L. Wright. 1998. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27:877-880.
19. Petracca, R., F. Falugi, G. Galli, N. Norais, D. Rosa, S. Campagnoli, V. Brugio, E. Di Stasio, B. Girardina, M. Houghton, S. Abrignani, and G. Gransi. 2000. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74:4824-4830.
20. Pilot-Matias, T. J., R. J. Carrick, P. F. Coleman, T. P. Leary, T. K. Surowy, J. N. Simons, A. S. Muerhoff, S. L. Buijk, M. L. Chalmers, G. J. Dawson, S. M. Desai, and I. K. Mushahwar. 1996. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 225:282-292.
21. Polgreen, P. M., J. Xiang, Q. Chang, and J. T. Stapleton. 2003. GB virus type C/hepatitis G virus: a nonpathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect. 5:1255-1261.
22. Rey, D., J. Vidinic-Moularde, P. Meyer, C. Schmitt, S. Fritsch, J. M. Lang, and F. Stoll-Keller. 2000. High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur. J. Clin. Microbiol. Infect. Dis. 19:721-724.
23. Rosa, D., S. Campagnoli, Q.-L. Choo, E. Guenzi, L. Cousens, M. Chin, C. Dong, A. J. Weiner, J. Y. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759-1763.
24. Sauleda, S., J. I. Esteban, J. M. Hernandez, H. Reesink, D. Castella, J. Quer, G. Hess, R. Esteban, and J. Guardia. 1999. Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood. Transfusion 39:633-638.
25. Schmolke, S., M. Tacke, U. Schmitt, A. M. Engel, and B. Ofenloch-Haehnle. 1998. Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization. J. Virol. 72:4541-4545.
26. Simons, J. N., S. M. Desai, D. E. Schultz, S. M. Lemon, and I. K. Mushahwar. 1996. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genomic organization. J. Virol. 70:6126-6135.
27. Simons, J. N., T. P. Leary, G. J. Dawson, T. J. Pilot-Matias, A. S. Muerhoff, G. G. Schlauder, S. M. Desai, and I. K. Mushahwar. 1995. Isolation of novel virus-like sequences associated with human hepatitis. Nat. Med. 1:564-569.
28. Stapleton, J. T. 2003. GB virus type C/hepatitis G virus. Semin. Liver Dis. 23:137-148.
29. Stapleton, J. T., C. F. Williams, and J. Xiang. 2004. GB virus C: a beneficial infection? J. Clin. Microbiol. 42:3915-3919.
30. Tacke, M., K. Kiyosawa, K. Stark, V. Schlueter, B. Ofenloch-Haehnle, G. Hess, and A. M. Engel. 1997. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349:318-320.
31. Tacke, M., S. Schmolke, V. Schlueter, S. Sauleda, J. I. Esteban, E. Tanaka, K. Kiyosawa, H. J. Alter, U. Schmitt, G. Hess, B. Ofenloch-Haehnle, and A. M. Engel. 1997. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26:1626-1633.
32. Tanaka, E., K. Kiyosawa, K. Shimoda, K. Hino, M. Tacke, S. Schmolke, A. M. Engel, and G. Hess. 1998. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. J. Viral Hepatitis 5:153-159.
33. Tanaka, E., M. Tacke, M. Kobayashi, Y. Nakatsuji, K. Kiyosawa, S. Schmolke, A. M. Engel, G. Hess, and H. J. Alter. 1998. Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J. Clin. Microbiol. 36:110-114.
34. Thomas, D. L., D. Vlahov, H. J. Alter, R. Marshall, J. Astemborski, and K. E. Nelson. 1998. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J. Infect. Dis. 177:539-542.
35. Tillmann, H. L., S. Heringlake, C. Trauwein, D. Meissner, B. Nashan, H. J. Schlitt, J. Kratochvil, J. Hunt, X. Qiu, C. Lou, R. Pichlmayr, and M. P. Manns. 1998. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 28:379-384.
36. Williams, C. F., D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, G. Hess, and J. T. Stapleton. 2004. Persistent GB virus C infection and survival in HIV-infected men. N. Engl. J. Med. 350:981-990.
37. Wünschmann, S., D. Klinzman, J. Medh, D. Klinzman, W. N. Schmidt, and J. T. Stapleton. 2000. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low density lipoprotein receptor. J. Virol. 74:10055-10062.
38. Xiang, J., S. Wunschmann, W. N. Schmidt, J. Shao, and J. T. Stapleton. 2000. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J. Virol. 74:9125-9133.
39. Xiang, J., S. Wunschmann, D. J. Diekema, D. Klinzman, K. D. Patrick, S. L. George, and J. T. Stapleton. 2001. Effect of coinfection with GB virus C (hepatitis G virus) on survival among patients with HIV infection. N. Engl. J. Med. 345:707-714.
40. Xiang, J., S. Wunschmann, D. Klinzman, S. L. George, W. N. Schmidt, D. R. LaBrecque, and J. T. Stapleton. 2002. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays. J. Med. Virol. 68:537-543.
41. Xiang, J., S. L. George, S. Wunschmann, Q. Chang, D. Klinzman, and J. T. Stapleton. 2004. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 363:2040-2046.
42. Xiang, J., M. A. Sathar, J. H. McLinden, D. Klinzman, Q. Chang, and J. T. Stapleton. 2005. South African GB virus C isolates: interactions between genotypes 1 and 5 GBV-C isolates and the human immunodeficiency virus. J. Infect. Dis. 192:2147-2151.
43. Zhang, W., K. Chaloner, H. L. Tillmann, C. F. Williams, and J. T. Stapleton. 2006. Effect of early and late GBV-C viremia on survival of HIV infected individuals: a meta-analysis. HIV Med. 7:173-180.